Prudential PLC 6-K, filed Aug 10, 2022
Prudential PLC (PUK)
6-K
2022-08-10
For: 2022-08-10
View Original
Added on
July 07, 2026
About this 6-K
Prudential PLC filed this 6-K on August 10, 2022.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
For the month of August,
2022
PRUDENTIAL PUBLIC LIMITED COMPANY
(Translation
of registrant's name into English)
1 Angel Court, London,
England, EC2R 7AG
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual
reports
under
cover Form 20-F or Form 40-F.
Form
20-F X
Form 40-F
Indicate
by check mark whether the registrant by furnishing the
information
contained
in this Form is also thereby furnishing the information to
the
Commission
pursuant to Rule 12g3-2(b) under the Securities Exchange Act of
1934.
Yes
No X
If
"Yes" is marked, indicate below the file number assigned to the
registrant
in
connection with Rule 12g3-2(b): 82-
10
August 2022
Prudential plc appoints Arijit Basu and Claudia
Suessmuth-Dyckerhoff
as Non-executive Directors
Prudential plc (Prudential) announces the appointment of Arijit
Basu and Claudia Suessmuth-Dyckerhoff as Non-executive
Directors. Mr Basu will join the Board with effect from 1
September 2022 and will also join the Audit Committee and
Responsibility & Sustainability Working Group. Dr
Suessmuth-Dyckerhoff’s appointment is subject to regulatory
approval and the effective date of her appointment and any
committee memberships will be confirmed in due course.
Mr Basu
has extensive experience in the banking and insurance industries in
India. He was Managing Director and CEO of SBI Life Insurance
Company, one of India’s leading life insurers, from 2014
until 2018 and took it public in 2017. He has held senior positions
at State Bank of India (SBI Bank) in a career spanning nearly 40
years. He is also a member of the Academic Advisory Council of the
College of Supervisors established by the Reserve Bank of India
(RBI) to advise the regulator on supervisory colleges.
Dr
Suessmuth-Dyckerhoff has a deep and broad knowledge of the
healthcare services sector and health technology across China and
the broader Asia-Pacific region. She has spent much of her career
based in Shanghai and, more recently, in Hong Kong and has worked
with healthcare providers, governments, insurers, pharmaceuticals
and medical device companies.
Shriti Vadera, Chair of Prudential plc, said: "I am
delighted that we have been able to appoint two new Non-executive
Directors with the knowledge and experience of insurance, health
and technology in Asia that Claudia and Arijit bring."
|
Media
|
|
Investors/Analysts
|
|
|
Simon
Kutner
|
+44
(0)7581 023 260
|
Patrick
Bowes
|
+44
(0)20 3977 9702
|
|
Ping
Ping Tan
|
+65
9845 8904
|
William
Elderkin
|
+44
(0)20 3977 9215
|
Notes to Editors
About Arijit Basu
Mr Basu
has an in depth understanding of the life insurance sector, having
served as Managing Director and CEO of SBI Life Insurance Company
Ltd (a subsidiary of SBI Bank, which successfully listed in 2017),
from 2014 to 2018. He was also a consultant to the Life Insurance
Corporation of India in preparation for its IPO in May
2022.
Mr Basu
was appointed chairman of the Board of HDB Financial Services Ltd
in June 2021, a leading financial services firm and subsidiary of
HDFC Bank Ltd. He is a senior advisor to leading firms, including
Ares SSG, AZB & Partners and Deloitte Shared Services India
LLP. In January 2021 he was appointed by the RBI as a member of its
Academic Advisory Council. He is also a director of Peerless
Hospitex Hospital and Research Center Ltd.
Mr Basu
retired as the Managing Director of SBI Bank in September 2020
having joined the bank in 1983. He held a number of senior
positions at the bank, across Retail, Corporate and International
Banking, Business Process Re-Engineering, IT and Risk
Management.
Mr Basu
holds an Honours degree in Economics and a Master’s degree in
History from the University of Delhi.
Age
61
About Claudia Suessmuth-Dyckerhoff
Dr
Suessmuth-Dyckerhoff joined the global consultancy firm McKinsey
& Partners in 1995 and worked in a number of senior roles. She
was responsible for helping to build the firm’s healthcare
Services and Systems sector in Asia Pacific, working with the
Chinese Ministry of Health to help develop their views on
China’s national healthcare systems. Much of the client work
during this period involved transformation through technology,
digital and data and her board experience in recent years has
helped her develop valuable insights around the implementation of
this in healthcare services. She has experience in China having
been based in Shanghai for nearly 15 years and in Hong Kong for a
further two years.
Dr
Suessmuth-Dyckerhoff has a portfolio of non-executive directorship
roles, mostly in the healthcare and healthcare technology sectors.
She is currently a non-executive director of the following listed
companies: Ramsay Health Care Ltd, Clairant AG and Hoffman-La Roche
AG. She is also a non-executive director of Huma Therapeutics Ltd,
QuEST Global Services Private Ltd and an advisor to aMoon Ventures
Y.SH. Ltd.
Dr
Suessmuth-Dyckerhoff holds a Ph.D in Business Administration from
the University of St. Gallen.
Age
55
Shareholding
Neither
Mr Basu nor Dr Suessmuth-Dyckerhoff hold any interest in shares of
Prudential within the meaning of Part XV of the Securities and
Futures Ordinance (Chapter 571 of the Laws of Hong
Kong).
Length of service
Non-executive
Directors are usually appointed for an initial three-year term.
They are typically expected to serve for two three-year terms,
although the Board may invite them to serve for an additional
period.
Remuneration
Non-executive
Directors are not eligible to participate in annual bonus plans,
long-term incentive plans or pension arrangements. Their fees are
determined by the Board and reflect their individual
responsibilities, including committee membership as
appropriate.
The
annual fee on appointment for both Mr Basu and Dr
Suessmuth-Dyckerhoff as Non-executive Directors will consist of a
basic fee of £102,000. Mr Basu will receive additional fees of
£30,000 for his membership of the Audit Committee and
£22,000 for his membership of the Responsibility &
Sustainability Working Group.
Regulatory disclosures
Both Mr
Basu and Dr Suessmuth-Dyckerhoff are considered independent for the
purposes of the UK Corporate Governance Code and the Rules
Governing the Listing of Securities on The Stock Exchange of Hong
Kong Limited (Hong Kong Listing Rules).
Both Mr
Basu and Dr Suessmuth-Dyckerhoff will also join the Board of
Prudential Corporation Asia Limited (PCAL), a wholly-owned
subsidiary of Prudential. Mr Basu will join the Board of PCAL with
effect from 1 September 2022. Dr Suessmuth-Dyckerhoff’s
appointment is subject to regulatory approval.
Save as disclosed above, there is no further information required
to be disclosed pursuant to Listing Rule 9.6.13 (1) - (6) of the
Listing Rules of the Financial Conduct Authority and Rule 13.51(2)
of the Hong Kong Listing Rules.
About Prudential
plc
Prudential plc provides life and health insurance and asset
management in Asia and Africa. The business helps people get the
most out of life, by making healthcare affordable and accessible
and by promoting financial inclusion. Prudential protects
people’s wealth, helps them grow their assets, and empowers
them to save for their goals. The business has more than 19 million
life customers and is listed on stock exchanges in London (PRU),
Hong Kong (2378), Singapore (K6S) and New York (PUK). Prudential is
not affiliated in any manner with Prudential Financial, Inc. a
company whose principal place of business is in the United States
of America, nor with The Prudential Assurance Company Limited, a
subsidiary of M&G plc, a company incorporated in the United
Kingdom. https://www.prudentialplc.com/.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
Date: 10 August 2022
|
|
PRUDENTIAL
PUBLIC LIMITED COMPANY
|
|
|
|
|
|
By:
/s/ Thomas S. Clarkson
|
|
|
|
|
|
Thomas
S. Clarkson
|
|
|
Company
Secretary
|